Evidence map›Paper›PMID 38125876›Full record

ArticleFrontiers in cell and developmental biology2023

Differential regulation of MYC expression by

Naoe Harafuji, Chaozhe Yang, Maoqing Wu, Girija Thiruvengadam, Heather Gordish-Dressman, R Griffin Thompson, P Darwin Bell, Avi Z Rosenberg, Claudia Dafinger, Max C Liebau and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. c-Myc: an emerging participant in heart failure.Frontiers in cardiovascular medicine · 2026
    Review
  4. MYC: there is more to it than cancer.Frontiers in cell and developmental biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Naoe Harafuji *Center for Translational Research, Children's National Hospital, Washington, DC, United States.
Chaozhe Yang *Center for Translational Research, Children's National Hospital, Washington, DC, United States.
Maoqing WuCenter for Translational Research, Children's National Hospital, Washington, DC, United States.
Girija ThiruvengadamCenter for Translational Research, Children's National Hospital, Washington, DC, United States.
Heather Gordish-DressmanCenter for Translational Research, Children's National Hospital, Washington, DC, United States.
R Griffin ThompsonHeersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, United States.
P Darwin BellHeersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, United States.
Avi Z RosenbergDepartment of Pathology, Johns Hopkins University, Baltimore, MD, United States.
Claudia DafingerDepartment of Pediatrics and Center for Molecular Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.
Max C LiebauDepartment of Pediatrics, Center for Family Health, Center for Rare Diseases and Center for Molecular Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.
Zsuzsanna BebokHeersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, United States.
Ljubica CaldovicCenter for Genetic Medicine Research, Children's National Hospital, Washington, DC, United States.
Lisa M Guay-WoodfordCenter for Translational Research, Children's National Hospital, Washington, DC, United States.
Children's National · USUniversity of Alabama at Birmingham · USJohns Hopkins University · USUniversity Hospital Cologne · DEUniversity of Cologne · DE

Funding

Decoding reno-protective mechanisms in mouse Pkhd1 models: Implications for ARPKD therapeuticsR01DK121530 · NIDDK · CHILDREN'S RESEARCH INSTITUTE · PI CALDOVIC, LJUBICA MORIZONO, GUAY-WOODFORD, LISA MARIE · 2020 to 2024
$1.9M
NIDDK NIH HHS R01 DK121530
6 · The paper itself

Abstract

Autosomal recessive polycystic kidney disease (ARPKD; MIM#263200) is a severe, hereditary, hepato-renal fibrocystic disorder that leads to early childhood morbidity and mortality. Typical forms of ARPKD are caused by pathogenic variants in the

Indexed as

ARPKDCys1cystinFPCMYCPKHD1

Identifiers

PMID38125876
PMCPMC10731465
OpenAlexW4388796823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.